Federal contract award
75A50325F80009
DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | ASPR/ORM-SNS |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79720D0198 |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $98.7M |
| Current contract value | $98.7M |
| Potential contract value / ceiling | $168.0M |
| Start date | Jun 23, 2025 |
| Current end date | Jan 4, 2027 |
| Potential end date | Jun 22, 2029 |
| Latest award activity | Dec 12, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 12, 2025 | P00002 | $0 | MODIFICATION TO UPDATE THE PERIOD OF PERFORMANCE ON ORDERING PERIOD 2. |
| Aug 12, 2025 | P00001 | $57.7M | EXERCISE OPTIONAL ORDERING PERIOD YEAR 2 DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS |
| Jun 18, 2025 | 0 | $41.0M | DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS |
Estimated positioning window
Jun 22, 2028 – Dec 22, 2028
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2029-06-22 (971 days from calculation)
- +15 points
- 31 historical awards in this buyer and category group
- +15 points
- 3 recorded award transactions
- +5 points
- Latest award action: 2025-12-12
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.